Study of Regorafenib in Patients With Advanced Myeloid Malignancies
Clinical trial NCT03042689 · COMPLETED
Trial details
- NCT number
- NCT03042689
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-17
- Primary completion
- 2021-09-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.